BioCryst Pharmaceuticals
BCRX
BCRX
272 hedge funds and large institutions have $1.31B invested in BioCryst Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 110 increasing their positions, 68 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
272
Holders Change
+14
Holders Change %
+5.43%
% of All Funds
3.69%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
41
Increased
110
Reduced
68
Closed
24
Calls
$9.58M
Puts
$4.81M
Net Calls
+$4.78M
Net Calls Change
+$1.17M
Top Buyers
1 |
Millennium Management
New York
|
+$22.7M |
2 |
UBS Group
Zurich,
Switzerland
|
+$16.2M |
3 |
D.E. Shaw & Co
New York
|
+$9.55M |
4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$7.28M |
5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$5.88M |